Bioleap is a deeptech life sciences company that uses a Hybrid-AI biosimulation platform to build auditable, scientifically grounded mechanistic models. The platform integrates physics, biology, and machine learning to provide causal drug insight and predictive simulations in weeks, accelerating therapeutic discovery and reducing the risk of drug development